Poly(A)' RNA isolated from the human breast cancer cell line MCF-7 was fractionated by sucrose gradient centrifugation and fractions enriched in estrogen receptor (ER) mRNA were used to prepare randomly primed cDNA libraries in the AgtlO and Agtll vectors. Clones corresponding to ER sequence were isolated from both libraries after screening with either ER monoclonal antibodies (Xgtll) or synthetic oligonucleotide probes designed from two peptide sequences of purified ER (XgtlO). Five cDNA clones were isolated by antibody screening and five were isolated after screening with synthetic oligonucleotides. The two largest ER cDNA clones, XOR3 (1.3 kilobase pairs) and XOR8 (2.1 kilobase pairs), isolated by using antibodies and oligonudeotides, respectively, were able to enrich selectively for ER mRNA by hybrid-selection. Furthermore, AOR8 contains the DNA sequence expected from the two ER peptides and crosshybridizes with each of the other ER cDNA dones. These results demonstrate that the clones isolated correspond to the ER mRNA sequence. Use of XOR8 as a hybridization probe revealed a single poly(A)+ RNA band of %6.2 kilobase pairs in the ER-containing human breast cancer cell lines MCF-7 and T47D. In contrast, no hybridization was seen in the human ER-negative cell line HeLa. The same probe hybridizes to a chicken gene that is expressed in oviduct tissue as a 7.5-kilobase-pair poly(A)+ RNA.
Estrogens, in common with other steroid hormones, regulate gene expression in target cells through their interaction with specific receptors (for review, see ref. 1) . The presence of estrogen receptors (ER) can be determined either by their high affinity binding for [3H]estradiol (2) or by using specific monoclonal antibodies (3, 4) . Recent studies have suggested that the estrogen-free receptor is localized predominantly in the nuclear compartment (5, 6) , where it is loosely bound until its association with estradiol converts the receptor to an active form with the ability to bind tightly in the genome (2) . The activated complex is believed to act directly at some, as yet, ill-defined chromatin site(s), resulting in specific changes in gene expression, although the molecular mechanism by which ER complexes are able to modify the expression of specific genes is so far unknown.
Further understanding of this mechanism has been severely hampered due to the low level of ER expression. A high level of expression of ER cDNA, in both homologous as well as heterologous systems, should allow further insight into ER structure and function at the molecular level. Since expression of the ER gene is both tissue-specific and developmentally regulated, isolation of the ER gene should lead to the identification of the responsible sequence elements.
ER are believed to play an important role in the growth and development of a subset of hormone-dependent human breast cancers. Approximately one-third of all breast cancer tumors contain significant amounts of ER and about twothirds of these are able to respond objectively to some form of anti-estrogen endocrine therapy (2, 7) . Therefore, a better understanding either of the mechanism of estrogen action in these tumors or of the way in which their expression is regulated may lead to an improvement in the therapy of these cancers.
We describe here the isolation of several cDNA clones corresponding to the mRNA sequence of the human ER.
MATERIALS AND METHODS
Preparation of cDNA Libraries. Sucrose gradient fractions 21-23 (see legend to Fig. 1 ) that are enriched in receptor mRNA were pooled and used for cDNA synthesis and cloning into Xgt vectors essentially as described by Huynh et al. (8) and Young and Davis (9, 10) . Briefly, 5 ,ug of enriched RNA was reverse transcribed in the presence of 35 pmol of a random primer consisting of a 13-mer synthetic oligonucleotide synthesized by using a mixture of each nucleotide at each position (11) . After boiling for 90 sec, the second strand was synthesized with DNA polymerase I and the cDNA was treated with S1 nuclease at 25°C. Any internal EcoRI sites were protected by treatment with EcoRI methylase and the extremities of the cDNA were made flush by using T4 DNA polymerase. An equal mass of EcoRI linker (generally 1 ,ug of cDNA with 1 ,ug of the linker GGAATTCC) was ligated to the cDNA overnight at 16°C by using T4 DNA ligase. The cDNA was digested with EcoRI, separated from excess linker by chromatography on a Bio-Gel A-50m column, and ligated at a molar ratio of2:1 (cDNA:X phage DNA) overnight at 4°C by using either EcoRI-digested XgtlO or EcoRIdigested, alkaline phosphatase-treated Xgtll (8, 9) . After packaging the DNA in vitro (12) tTo whom all correspondence should be addressed.
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,B-D-thiogalactopyranoside) for 2 hr each. Only phage plaques producing duplicate signals were studied further.
Oligonucleotide Screening. Oligonucleotides were synthesized either semimanually (11) or automatically (Sam One, Biosearch, San Rafael, CA) by using the phosphotriester method. The XgtlO cDNA library was plated onto E. coli C600hfl at 3000-5000 plaques per 8.5-cm plate and duplicate filters were prepared, which were hybridized with oligonucleotide mixture A (probe A, Fig. 3 ) at 35°C and probes B and C (Fig. 3) at 50°C as described by Wallace et al. (13) . Filters were washed at 0°C in 0.9 M NaCl/90 mM sodium citrate for probe A or at 0°C in 0.9 M NaCl/90 mM sodium citrate, followed by a 15-min wash at 50°C in 0.3 M NaCl/30 mM sodium citrate for probes B and C. Sequencing of selected clones was performed in M13 mp8 by using the dideoxy technique (14) .
RESULTS
Enrichment in ER mRNA. Poly(A)+ RNA from the human breast cancer cell line MCF-7 (15) was fractionated on sucrose gradients containing methylmercury hydroxide, and RNA sedimenting between =23 S and =32 S was translated in vitro. The proteins from each translation reaction were immunoprecipitated by using a mixture of monoclonal antibodies prepared against the MCF-7 ER (3, 4) and displayed by polyacrylamide gel electrophoresis and fluorography ( Fig.  1) . Two proteins of =65 kDa and -46 kDa were observed (Fig. 1) . The peak of the corresponding mRNA was found in fractions 21 and 22 (Fig. 1, lanes 5 and 6) , representing an mRNA that sedimented faster than 28S rRNA. Purified ER labeled with 125I comigrated with the 65-kDa in vitro translation product under these electrophoresis conditions (not shown), supporting the conclusion that fractions 20-23 were (Fig. 3) . Of the 300,000 XgtlO cDNA clones screened with a mixture of 24 14-mers (probe A, Fig. 3 ), 35 were positive. To exclude false positives due to hybridization of the probe to closely homologous sequences, these 35 clones were screened with a 41-mer oligonucleotide (probe B) corresponding to the whole of peptide 99 (Fig. 3) . Three clones, XOR5, XOR6, and XOR8, were also positive with probe B. Two additional clones, XOR9 and XOR10, were isolated by screening the original 300,000 clones with a 41-mer oligonucleotide (probe C) corresponding to peptide 80 (Fig. 3) . Interestingly, 1 for a further 2 hr at 37°C. The filter was cut into strips and each was incubated with one ofthe four ER monoclonal antibodies by using the standard assay as described for the screening. Amino acid sequence of ER peptides, nucleotide sequence of the oligonucleotide probes, and amino acid sequences deduced from the corresponding cDNA sequence of the XOR8 clone. Probe A, a mixture of 24 14-mer oligonucleotides, was designed from peptide 99 by using all of the possible codons of the least ambiguous region (His-Gln-Ile-Gln-Gly). Probes B and C were chosen by using the most common codon for each amino acid after taking into consideration the frequency of human codon usage (19) .
clones hybridizing with probes A and B, XOR8, also hybridized with probe C. That probes B and C were derived from two independent peptide sequences suggested strongly that XOR8 contains cDNA sequences corresponding to ER mRNA. The regions of XOR8 that hybridized to probes B and C were subcloned into vector M13 mp8 and sequenced (Fig.  3) . The two corresponding amino acid sequences match almost perfectly those of peptides 80 and 99, confirming that XOR8 contains an ER cDNA insert. The last amino acid of peptide 80 is glutamine instead of the leucine predicted from the nucleotide sequence. This single discrepancy is most likely related to a decrease in the accuracy of the amino acid sequence after several steps of microsequencing.
The cDNA insert from XOR8 was used as a probe for cross-hybridization to each of the XOR clones. As shown in with EcoRI and electrophoresed on a 1% agarose gel. After transfer to nitrocellulose, the filter was hybridized with the nick-translated insert of XOR8 by using standard techniques (12) . Clones XORO to XOR4 were isolated from the Xgtll cDNA library by using monoclonal antibodies, whereas XOR5, XOR6, XOR8, XOR9, and XOR10 were isolated from a XgtlO library by using oligonucleotide probes. The contain cDNA inserts corresponding to the ER mRNA sequence.
Hybrid-Selection and in Vitro Translation ofER mRNA. The largest clone isolated by antibody screening, XOR3 (1.3 kb), and the largest clone obtained by oligonucleotide screening, XOR8 (2.1 kb), were used to select ER mRNA from sucrose gradient fractions. The mRNA selected by hybridization with either XOR3 or XOR8 was then translated in a rabbit reticulocyte lysate system and the products were electrophoresed on a NaDodSO4/polyacrylamide gel before or after immunoprecipitation with the four monoclonal antibodies (Fig. 5) . Even without immunoprecipitation a strong band of =65 kDa was apparent in both cases, and after immunoprecipitation Biochemistry: Walter et A only two bands of 65 kDa and 46 kDa were seen. These two bands corresponded to those seen when total poly(A)+ mRNA or sucrose gradient-enriched mRNA fractions were translated in vitro and immunoprecipitated (Fig. 1) . These results support further the conclusion that the XOR clones contain ER cDNA inserts.
Sequence Homology Between Human ER cDNA and Chicken RNA and DNA Revealed by RNA Transfer and Southern Analyses. The same amount at total poly(A)+ isolated from laying hen oviduct, HeLa cells, and the human breast cancer cell lines MCF-7 and T47D (22) was electrophoresed on an agarose gel and transferred to diazobenzyloxymethyl-paper. When hybridized with the insert from XOR8 a single band corresponding to an RNA of -6.2 kb was observed for both the T47D and MCF-7 cell lines (Fig. 6A) . The T47D cell line contains less ER than the MCF-7 cell line when determined by using a hormone-binding assay (22) . The RNA transfer blot suggests that this is also true at the mRNA level (Fig. 6,  lanes 3 and 4) . No hybridization was observed with the human ER-negative cell line HeLa. Interestingly, the human El probe was capable of hybridizing to a chicken oviduct poly(A)+ RNA of -7.5 kb under high-stringency hybridization conditions. In this respect, we note that H222 and H226 monoclonal antibodies react with chicken oviduct ER (4).
Further evidence of a homology between the human ER cDNA sequence and the chicken gene was obtained from Southern analysis (Fig. 6B) . Human EcoRI-digested genomic DNA hybridized with the nick-translated cDNA insert of XOR8 indicates that the organization of the human ER gene is complex (Fig. 6B) (23) . The RNA was transferred to diazobenzyloxymethyl-paper and hybridized with the nick-translated insert of XOR8 (24) . The contrast, the genomic organization of the chicken gene appears to be less complex, but this may simply reflect the lack of hybridization of some portion of the human cDNA with the chicken gene when hybridized under high-stringency conditions. Hybridization of the cDNA of XOR8 with genomic blots ofhuman-mouse hybrid cell lines has localized the human ER gene to human chromosome 6 (J. L. Mandel, personal communication).
DISCUSSION
The use of well-characterized monoclonal antibodies against the human ER purified from MCF-7 cells in combination with a cDNA expression library in Xgtll and of synthetic oligonucleotide probes, derived from amino acid sequences of the purified protein, with a XgtlO cDNA library, has allowed us to isolate cDNA clones corresponding to this receptor. One of these clones, XOR8, was found to contain sequences corresponding to those expected from two peptide sequences of the purified receptor. Two of these clones, XOR3, isolated by antibody screening, and XOR8, isolated by using oligonucleotide probes, were able to hybrid-select an MCF-7 cell mRNA that could be translated in vitro to yield predominantly a protein that has the same size as the ER (-65 kDa) and is selectively immunopurified with the ER monoclonal antibodies. Thus, the cDNA clones presented here correspond to human ER mRNA.
Whenever the in vitro, translation products of the MCF-7 poly(A)+ RNA were examined, either before or after hybridselection, a weaker additional band of -46 kDa was observed. The nature of the smaller protein is at present unknown. However, it may correspond to an in vitro degradation product of the larger protein or to a premature termination oftranslation, since it was only observed in those denaturing sucrose gradient fractions that yielded the 65-kDa protein (see Fig. 1 ). The 46-kDa component is not observed after immunoprecipitation of iodinated purified MCF-7 ER (unpublished results).
The amount of information required to code for a protein of 65 kDa corresponds to an RNA of x2 kb. Since the size of the MCF-7 cell ER mRNA appears to be =6.2 kb, a large fraction of the mRNA should be untranslated. In the vast majority of eukaryotic mRNAs the most 5' AUG is used to initiate translation (25) . Therefore, the human mRNA is likely to contain a short 5' and a very long 3' untranslated region. This is not unique to the ER mRNA as several other receptor mRNAs appear to have a similar structure (26) (27) (28) .
One of the most interesting questions related to steroid hormone research is how does the binding ofa hormone to the receptor activate gene expression at the transcriptional level? It is likely that the ER behaves in a way similar to those of the progesterone and glucocorticoid receptors and that specific promoter elements are in some way responsible for specific gene activation, possibly by directly binding the hormone-receptor complex (refs. [29] [30] [31] [32] [33] ; see also references in ref. 34) . Therefore, the ER protein may consist of at least two functional domains, the hormone and DNA binding sites, as shown previously (4) . We have isolated the chicken ER cDNA by using XOR8 as a probe (unpublished results). Sequence comparison between the human and chicken ER cDNAs, together with in vitro genetics, should permit location of these functional domains, whose tertiary structure could subsequently be studied. Expression of ER cDNA in transgenic mice under the control of a variety of promoters may help to evaluate the role of ER in regulation of gene expression during development and in terminally differentiated cells. This could be further examined by transfection of an ER cDNA expression vector into cells together with an estrogen-regulated gene, such as pS2 (35) . Similar studies using the ER gene should allow those regions involved in the tissue-specific and developmental regulation ofthe gene to be localized.
Finally, loss of estrogen dependence in some human breast cancers is often associated with the appearance of more malignant tumors (7) . The expression of anti-sense ER mRNA preventing the expression of the endogenous ER in established breast cancer cell lines will offer an opportunity to directly examine the effect ofthe ER on the growth ofthese cells. This may lead to a better understanding of the role of the ER in human breast cancer.
